HEPXIA

Welcome to the Brand page for “HEPXIA”, which is offered here for Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer;chemical compositions containing nucleic acids for use in the manufacture of gene therapy preparations;instruments and apparatus for the administration of gene therapy, syringes, scalpels, catheters, tubes for the administration of gene therapy products;scientific and medical research and development, medical services, genetic engineering services, biotechnology services all in relation to the treatment of viral and bacterial infections, cancer, hiv and aids related infections and bodily conditions associated with impaired immunosystems;.

Its status is currently believed to be active. Its class is unavailable. “HEPXIA” is believed to be currently owned by “Oxford BioMedica plc”.